Information For Authors
- Manuscript Submission Guidelines
- Open Access Policy
- NIH/HHMI Wellcome Trust Policies
- Self-Archiving Policy
Journal of Endourology Case Reports
Instructions for Authors
Aims & Scope
Journal of Endourology Case Reports is an online-only forum for sharing clinically interesting and educational case reports on the treatment and surgical management of urologic diseases, including controversial cases and novel use of technology. A sister publication to Journal of Endourology, JE Case Reports provides rapid peer review and publication and wide dissemination to urologist, fellows, residents, and trainees around the globe.
All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.
BASIC MANUSCRIPT SUBMISSION REQUIREMENTS**
- Length: 1,500 words, maximum 4 figures, maximum 4 references
- Structure and sections: Title; brief abstract; clinical history; physical exam; diagnosis; intervention; follow-up; outcomes; author disclosure
**For full, detailed instructions on submission, please see below.
Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc., unless other arrangements are made prior to publication, including CC-BY licensing. By submitting a manuscript to the Journal, the author(s) agree(s) to each of the above conditions. In addition, the author(s) explicitly assign(s) any copyrighted ownership he/she (they) may have in such manuscript to the Journal. Upon acceptance of any manuscript, all authors will receive a follow-up email with instructions on how to complete our online Copyright Agreement form. It is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications. FAILURE BY ALL AUTHORS TO SUBMIT THIS FORM WILL RESULT IN A DELAY OF PUBLICATION. The corresponding author is responsible for communicating with coauthors to make sure they have completed the online copyright form. Authors not permitted to release copyright must still return the form acknowledging the statement of the reason for not releasing the copyright. Alternatively, the copyright form may be completed by logging in to the system using an author’s credentials. Enter your Author Center and complete the forms located under “Manuscripts I Have Coauthored,” or “Manuscripts with Decisions” if you are listed as the corresponding author on the paper.
Journal of Endourology Case Reports is fully NIH-, HHMI-, and Wellcome Trust-compliant.
Archiving and Preservation
Mary Ann Liebert, Inc., deposits and archives all publications in Portico for long-term digital preservation.
Ralph V. Clayman
University of California, Irvine, United States
Arthur D. Smith
The Smith Institute for Urology, United States
Western University, Canada
Submitting to the Journal
Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract. Prior abstract publications should be described in the form of a footnote to the title.
All submissions must be submitted online via http://mc.manuscriptcentral.com/cren
Create An Account in Manuscript Central
If you do not already have an account in Manuscript Central for Journal of Endourology Case Reports, you will need to create one. Once you create your account, you may log in to the system to begin your submission.
PUBLICATION ETHICS AND MALPRACTICE STATEMENT
If applicable, it is incumbent upon the author(s) to obtain patient release statements of permission to reproduce any identifiable images of patients. The Journal does not provide a generic patient release form.
Any identifying information should not be published in descriptions or photographs unless the information is essential for scientific purposes and the patient (or parent/guardian) gives written informed consent for publication. Informed consent for this purpose requires that an identifiable patient be shown the manuscript to be submitted. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication.]] Nonessential identifying details should be omitted. Informed consent should be obtained if there is any doubt that anonymity can be maintained. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are de-identified, the manuscript should contain assurances/statements that such changes do not distort scientific meaning.
In keeping with patients' rights of privacy, the Journal does not require the submission of patient consent forms, but instead requires the author(s) to retain and archive all patient consent documentation. Upon submission of a manuscript for review, the authors must make a statement in a cover letter to the Editor/Journal which attests they have received and archived written patient consent.
Ethics of Experimentation
All articles involving the use of human fetuses, fetal tissue, embryos, and embryonic cells must adhere to the US Public Law 103–41, effective December 13, 2001. (http://ethics.od.nih.gov/.)
Ethical Treatment of Animals
All peer-reviewed submissions containing animal experiments must comply with local and national regulatory principles, and contain a statement in the Materials and Methods section stating whether their national and institutional guidelines for the care and use of laboratory animals were followed.
It is incumbent upon the submitting author to ensure the accuracy and inclusion of all contributing authors’ names and affiliations upon original submission of the paper.
All authors listed in the text file of a manuscript MUST be entered into the submission system (Manuscript Central) as coauthors. Omission of any authors’ names in the system could result in erroneous publication. Inclusion in the manuscript file alone does not qualify. Once a paper is accepted for publication, changes in authorship – including the page proof stage – are NOT permitted. Changes in authorship after publication are strictly prohibited.
It is the Journal’s policy that a manuscript has only ONE corresponding author listed on a paper. This designation should be determined at the time of submission. Changes to corresponding authorship are not permitted after acceptance or in page proofs.
Submitting to the Journal
Case Reports are reviewed by the Editors within 14 days of submission. The final decision to accept or reject a case report is made by the Editors.
Manuscripts submitted to Journal of Endourology Case Reports will not be rejected solely on the basis of errors in sentence construction, syntax, and grammar. Journal of Endourology Case Reports strives to communicate meritorious cases from all countries, and reviews will not be compromised due to deficiencies in presentations. However, manuscripts which require substantial editing may, at the editors’ discretion, be un-submitted and referred to an editorial service for a fee (subsidized by the authors). Please contact Editing@liebertpub.com for more details. It is important to note that use of this or any other editing service does not guarantee acceptance.
Ethical Considerations in the Conduct and Reporting of Research: Protection of Human Subjects and Animals in Research*
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
*This portion of Instructions for Authors has been quoted directly from the Uniform Requirements for Manuscripts Submitted to Biomedical Journals website. For more information, visit www.icmje.org/ethical_6protection.html
Preparation of Manuscripts
Manuscripts should be should be prepared in Microsoft Word and double-spaced.
Please follow these guidelines for submitting figures:
- Do NOT embed art files into the main text of your manuscript
- Do NOT prepare figures in Word or a PDF document
- Name figure files using only alphanumeric characters. Do not use symbols, underscores, spaces, dots, or dashes.
- File names should be formatted with first author’s last name and the figure number. (Ex: SmithFig1)
- File names must be in English, alphanumeric characters.
- Line illustrations should be submitted at 900 dpi or higher
- Halftones and color should be submitted at a minimum of 300 dpi
- Save as either TIFF or EPS files.
- Black and White art must be submitted as grayscale
- Excel files cannot be uploaded. It is best to avoid submitted PowerPoint files. For directions on converting a Power Point slide to an acceptable format go to: www.liebertpub.com/MEDIA/pdf/ppconvert.pdf
Journal of Endourology Case Reports does not currently impose a charge for color illustrations.
The title page should contain: A) *the complete title of the paper; B) the full name, full mailing address, full contact information (telephone, fax, and e-mail address), and affiliations of each author. C) a brief running title consisting of no more than 45 characters (including spaces); D) the designation of the corresponding author, along with complete contact information including address and valid e-mail address. The full names, institutional addresses, and email addresses for all authors must be included on the title page.
Keywords: Include four to ten keywords representing the content of the paper.
Footnotes and abbreviations: List information such as prior conference presentation of the submitted material and a list of non-standard abbreviations (standard abbreviations need not be listed).
Abstract: The abstract must not exceed 350 words. Please do not use abbreviations, proprietary names, trademarks, or references in the abstract. The abstract should be organized into three sections: Background why the case is important or needs to be reported; Case presentation, brief details of the case including patient’s age, sex, and ethnic background; Conclusion, summarized conclusion of what the reader should learn from the case report and how to will add to our knowledge of treatment and surgical management of urologic diseases and novel use of technology.
Introduction and background: This section should briefly introduce the background of the case and a review of the disorder for non-specialist readers. If the case discusses drug interaction or new technology then details of common use or reported side effects should be noted along with a brief review of the literature. End this section with cogent statement of what is being reported in the paper.
Presentation of Case: This should present all pertinent details concerning the case(s) including a description of the patient's relevant demographic information; pertinent medical history; symptoms; any tests that were produced and a description of any treatment or intervention. For case series, details for all patients must be included. No patient names or identifying features.
Discussion and Literature Review (optional): This is an optional section for additional information not included in the case presentation. This section should also include a brief literature review to compare and evaluate the patient case for accuracy and uniqueness.
Conclusion: This section should state the conclusion of the case report and offer a cogent explanation to its importance and relevance. If novel, information should be included on how it will significantly advance knowledge of urologic diseases to ensure optimal patient care.
Acknowledgments: State funding sources and other assistance that were necessary for the conduct of the study.
Author Disclosure Statement: Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. Please see the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance. If no conflicts exist, the authors must state “No competing financial interests exist."
References: Should be cited in the text and listed numerically at the end of the paper in the order of citation, as detailed in instructions below.
Figures: Please do not include patient names or identifying features. Survival curves with two or more groups should be clearly labeled and disparately displayed for K-M survival curves.
Figure legends: These must be double-spaced in a separate file. For radiographic images, please describe the findings, add arrows, and use high quality original work. Avoid using poor quality intraoperative photo as they are often uninterpretable. Please make survival curves readable and, if appropriate, include statistical information.
Tables: Number these consecutively throughout the text. Tables should be prepared in a separate file, and should not be included as part of the main text document. Please include only one table per page and include footnotes to define abbreviations in the table.
Please upload individual files of all manuscript material — do NOT upload a single PDF file containing all text, figure, and table files of your paper. Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
References (PLEASE FOLLOW CAREFULLY)
References may be made to published work and papers in press. Reference citations are not permitted in the abstract of a paper. Authors are responsible for the accuracy of all literature citations. Work in progress, in preparation, unpublished work, and personal communications should be cited as footnotes to the text. References should be listed numerically in the text in the order of appearance as superscripted consecutive numbers, e.g., 1,2. Where there are more than two references within text, the citation should appear as hyphenated numbers, e.g., 1–3. The reference section should be typed double-spaced in numerical order of citation, with the first three authors listed, followed by et al. Abbreviations of journals titles should conform to those used in Medline. The following formats must be used:
Smith AD, Reinke DB, Miller R, et al. Percutaneous nephrostomy in the management of ureteral and renal calculi. Radiology 1979; 133:49-54.
Clayman RV, Casteneda-Zuniga WR: Patient selection and patient preparation. In: Techniques in Endourology: A Guide to the Percutaneous Removal of Renal and Ureteral Calculi. Chicago: Year Book Medical Publishers, Inc., 1986, pp 12–18.
If it is necessary to cite an abstract, this should be so designated. Authors are responsible for the accuracy of the references and are reminded that inaccurate references are highly frustrating to the reader, the cited author, and indexing services. Abbreviations of journal titles should follow Medline.
When a reference is unpublished data, a manuscript in preparation, or a manuscript submitted but not in press, it should be included in parentheses in the body of the text, and not cited in the reference list. Personal communications should also be listed parenthetically in text, and should contain the first initial and last name of the contact, as well as the month and year of the communication. Published manuscripts, and those that have been accepted and are pending publication, should be cited in the reference list.
Page proofs will be sent to the (one) corresponding author as designated when the manuscript was uploaded to Manuscript Central. It is the corresponding author’s responsibility to share the page proofs with co-authors and to coordinate all authors’ corrections into one proof. The Publisher will not accept corrections from multiple authors.
Changes in authorship in page proofs are generally NOT permitted.
Journal of Endourology Case Reports is published and owned by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone: (914) 740–2100; Fax: (914) 740–2101; Website: www.liebertpub.com; Email: firstname.lastname@example.org
Research Funder Compliance
Our open access publishing solutions allows you to easily comply with the open access policies of your institution, government and funding body. If you are employed or funded by the National Institute of Health (NIH), the Wellcome Trust, Research Councils UK (RCUK) or Howard Hughes Medical Institute (HHMI), you can find more information below.
Wellcome Trust Policy – To easily comply, you can choose to have your article published open access with open option or via an open access journal under the Creative Commons Attribution (CC BY) license. Remember to request the CC BY license when ordering open access. Publication charge will be covered by the Wellcome Trust.
Research Councils UK (RUCK) – To easily comply, you can choose to have your article published open access with open option or via an open access journal under the Creative Commons Attribution (CC BY)license. Remember to request the CC BY license when ordering open access. Publication charge will be covered by the RUCK.
HHMI and NIH Public Access Policy – In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final published article to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Authors are strongly encouraged to consider publishing with open option or via an open access journal to remove the 12 month embargo period.
Publishing in Subscription Journals
By signing the copyright transfer statement, authors still retain a set of rights that allow for self-archiving.
Authors may archive their preprint manuscripts (version prior to peer review) at any time without restrictions. Authors may archive their postprint manuscripts (accepted version after peer review) in institutional repositories, preprint servers, and research networks after a 12 month embargo. The 12 month embargo period begins when the article is published online. Postprints must not be used for commercial purposes and acknowledgement must be given to the final publication, and publisher, by inserting the DOI number of the article in the following sentence: “Final publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]”. Authors may archive on their personal website without an embargo provided their manuscript is updated with an acknowledgement to the publisher copyright and final published version.
The final published article (version of record) can never be archived in a repository, preprint server, or research network.
Publishing Open Access
Authors that wish to easily comply with funder or institutional open access mandates should consider publishing open access. Liebert Open Access option allows authors to make their research freely available online without restrictions. Additionally, Liebert Open Access option allows authors to retain copyright, archive and share the final published version of their article without restrictions. To publish open access please email email@example.com or visit Liebert Open Access for more information.